Home > Financial Ratios > ALEMBIC

ALEMBIC
Core EBITDA Growth

    Back to All Ratios
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for ALEMBIC
Please provide your vote to see the results

ALEMBIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 51.036.731.44383.10-77.92

What is the latest Core EBITDA Growth ratio of ALEMBIC ?

The latest Core EBITDA Growth ratio of ALEMBIC is 51.03 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202551.03
Mar20246.73
Mar20231.44
Mar2022383.10
Mar2021-77.92

How is Core EBITDA Growth of ALEMBIC Trending?

Years Core EBITDA Growth % Change
Mar2025 51.03
658.25
Mar2024 6.73
367.36
Mar2023 1.44
-99.62
Mar2022 383.1
Positive
Mar2021 -77.92 -

Other Financial Ratios of ALEMBIC


Compare Core EBITDA Growth ratio of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹2,081.4 Cr -4.8% -17% -13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr 0.3% -1.3% -9% Stock Analytics


ALEMBIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

-4.8%

-17%

-13.2%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses